GlassScriptPhysician profile
Tracee Ridley-Pryor
NPI 1164941928
$3,701.38
in general payments reported to CMS, 2019-2025
22 companies · $1,047 in 2025
The $1,047 reported for 2025 was more than what 81% of Psychiatric/Mental Health (Nurse Practitioner) providers received nationally (typical 2025 total: $257).
See the full distribution for Psychiatric/Mental Health (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $495 · 2022: $1,031 · 2023: $645 · 2024: $483 · 2025: $1,047.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,176.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,175.52 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ucb, INC. | $686.95 | 2021-2025 | Fintepla, Briviact |
| Jazz Pharmaceuticals INC. | $429.21 | 2022-2025 | |
| Neurocrine Biosciences, INC. | $413.71 | 2022-2023 | Ingrezza |
| Neurelis, INC. | $371.02 | 2022-2025 | Valtoco |
| Axsome Therapeutics, INC. | $347.40 | 2023-2025 | Auvelity |
| Livanova USA, INC. | $228.27 | 2021-2023 | Vns Therapy Sentiva Model 1000 Generator |
| Upsher-Smith Laboratories LLC | $149.14 | 2023-2024 | |
| Nobelpharma America, LLC | $141.31 | 2025 | |
| Ptc Therapeutics, INC. | $125.00 | 2022 | |
| Tris Pharma INC | $123.57 | 2024 | Quillivant, Dyanavel Xr, Quillichew Er |
| E.R. Squibb & Sons, L.L.C. | $123.41 | 2025 | Cobenfy |
| Teva Pharmaceuticals USA, INC. | $103.20 | 2021 | |
| Seqirus USA INC | $87.42 | 2023 | |
| Zogenix INC. | $59.33 | 2021 | |
| Sk Life Science, INC. | $55.69 | 2021-2024 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Eisai INC. | $50.26 | 2021-2022 | |
| Immedica Pharma US, INC. | $45.19 | 2024-2025 | Ztalmy |
| Supernus Pharmaceuticals, INC. | $44.60 | 2021 | |
| Aquestive Therapeutics, INC. | $41.47 | 2021 | |
| Catalyst Pharmaceuticals, INC. | $40.86 | 2024-2025 | |
| Biocodex, INC. | $17.71 | 2023 | Diacomit |
| Azurity Pharmaceuticals, INC. | $16.66 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Tracee Ridley-Pryor listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.